LOS ANGELES, May 15 (Xinhua) -- The United States has started a clinical trial of an experimental universal influenza vaccine developed by researchers at the U.S. National Institutes of Health (NIH), the agency said on Monday.
The trial has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response, according to the NIH.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
